


Healthcare | Small Cap
Amrutanjan Health Care Ltd. demonstrates robust financial health, characterized by exceptional profitability, impressive growth, and a virtually debt-free status. The company's reliance on its own funds for financing assets provides a strong foundation of long-term stability, making it highly resilient. It has consistently expanded its revenues and profits, indicating strong market demand and operational success. Key strengths include outstanding profitability margins and efficient inventory management, which contribute to its healthy cash generation. However, the company shows more moderate performance in how efficiently it uses its total capital to generate sales. While fundamentally very strong, direct shareholder return metrics like earnings and book value per share are average. The future outlook is positive, driven by strong growth momentum and a pristine balance sheet. The main area of observation will be how effectively its large capital base is utilized to drive top-line sales and enhance shareholder value metrics over time.
Amrutanjan Health Care Ltd. demonstrates robust financial health, characterized by exceptional profitability, impressive growth, and a virtually debt-free status. The company's reliance on its own funds for financing assets provides a strong foundation of long-term stability, making it highly resilient. It has consistently expanded its revenues and profits, indicating strong market demand and operational success. Key strengths include outstanding profitability margins and efficient inventory management, which contribute to its healthy cash generation. However, the company shows more moderate performance in how efficiently it uses its total capital to generate sales. While fundamentally very strong, direct shareholder return metrics like earnings and book value per share are average. The future outlook is positive, driven by strong growth momentum and a pristine balance sheet. The main area of observation will be how effectively its large capital base is utilized to drive top-line sales and enhance shareholder value metrics over time.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
25.96
Industry Median
30.92
Small Cap Median
28.82
P/E RATIO
73.76
P/B RATIO
13.98
Industry Median
3.39
Small Cap Median
2.92
P/S RATIO
8.49
Industry Median
3.36
Small Cap Median
2.72
Others
PEG RATIO
4.98
EV/EBITDA RATIO
40.39
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹520 as on Aug 6, 2026.
The company has demonstrated exceptionally strong and broad-based growth. It has consistently expanded its revenues, operating profits, and net income at a very high rate. This comprehensive growth is also reflected in rising earnings for shareholders and an expanding asset base. This performance indicates a highly successful business strategy, strong market demand for its healthcare products, and a very positive trajectory for future expansion and continued profitability.
| Growth Ratios | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 34.65 | -3.68 | 2.29 | 17.91 | 12.03 |
| Operating Profit Growth Rate | 38.46 | -5.56 | 29.41 | 9.09 | 29.17 |
| Earnings Per Share (EPS) Growth | 4.52 | 22.77 | 19.72 | 38.24 | |
| Asset Growth Rate | -21.02 | 0 | -3.23 | 3.33 | 12.9 |
| Net Income Growth Rate | 0 | 0 | 20 | 25 | 40 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Jagsonpal Pharmaceuticals Ltd | 8.51 | 37.02 | Overvalued | 58.00 | 6.54 | 43.00 |
| 2 | Amrutanjan Health Care Ltd | 8.25 | 73.76 | Highly Overvalued | 31.00 | 20.03 | 21.00 |
| 3 | Windlas Biotech Ltd | 7.52 | 27.76 | Neutral | 105.00 | 32.19 | 66.00 |
| 4 | Lincoln Pharmaceuticals Ltd | 7.31 | 13.81 | Neutral | 98.00 | 43.88 | 88.00 |
| 5 | Morepen Laboratories Ltd | 7.12 | 45.91 | Neutral | 126.00 | 1.21 | 96.00 |
| 6 | Alembic Ltd | 7.06 | 7.01 | Undervalued | 90.00 | 4.85 | 317.00 |
| 7 | NGL Fine Chem Ltd | 6.98 | 44.01 | Overvalued | 73.00 | 67.39 | 48.00 |
| 8 | Syncom Formulations (India) Ltd | 6.92 | 16.27 | Undervalued | 77.00 | 0.81 | 76.00 |
| 9 | Sakar Healthcare Ltd | 6.89 | 67.13 | Highly Overvalued | 69.00 | 13.70 | 30.00 |
| 10 | Hester Biosciences Ltd | 6.54 | 37.59 | Neutral | 87.00 | 61.24 | 57.00 |
| 11 | Sigachi Industries Ltd | 6.49 | 11.55 | Highly Undervalued | 54.00 | -2.08 | -83.00 |
| 12 | SMS Pharmaceuticals Ltd | 5.94 | 32.80 | Neutral | 171.00 | 9.35 | 102.00 |
| 13 | Remus Pharmaceuticals Ltd | 5.31 | 25.82 | Neutral | 57.00 | 20.97 | 46.00 |
| 14 | IOL Chemicals & Pharmaceuticals Ltd | 5.31 | 34.79 | Undervalued | 269.00 | 4.69 | 138.00 |
| 15 | Indoco Remedies Ltd | 5.26 | -21.52 | Neutral | 142.00 | -0.61 | -99.00 |
| 16 | Ind-Swift Laboratories Ltd | 4.95 | 47.48 | Neutral | 45.00 | 4.89 | 41.00 |
| 17 | Venus Remedies Ltd | 4.83 | 23.37 | Neutral | 147.00 | 74.30 | 103.00 |
| 18 | Wanbury Ltd | 4.65 | 29.43 | Neutral | 88.00 | 18.93 | 43.00 |
| 19 | Solara Active Pharma Sciences Ltd | 4.34 | -249.32 | Neutral | 187.00 | -1.50 | -7.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral